Patient Guide: An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 22 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06075537
Status: ENROLLING_BY_INVITATION
Condition: Mucopolysaccharidosis II
Phase: PHASE2, PHASE3

Find a Study Location Near You

This study is available at 22 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Oakland, California
  • Chapel Hill, North Carolina
  • Cincinnati, Ohio
  • • And 19 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily